Skip to main content

Table 1 Selected drugs and corresponding reference standards

From: A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country

Name of the drug, dose, dosage formReference document
Acetaminophen 500 mg/tabMNP-2011,
NPM-0152-2014,
NPM-0046-2013
Acetylsalicylic acid, 81 mg/tabBP-2013,
NPM-0114-2014
Amlodipine 10 mg/tabNPM-0026-2013,
USP-36,
Registration document
Amoxicillin 500 mg/tabBP-2013,
CP-2010,
MNP-2011,
Cefotaxime 1.0 g/powder for injectionBP-2013,
CP-2010,
NPM-42-0088298102,
NPM-0052-2013,
Registration document,
USP-36
Cetirizine 10 mg/tabBP-2013,
CP-2010,
NPM-0224-2015,
Registration document,
USP-36
Ciprofloxacin 500 mg/tabBP-2013,
CP-2010,
MNP-2011,
USP-36
Citramon-P (Acetylsalicylic acid+acetaminophen+caffeine), 450 mg /tabMNP-2011,
NPM-0152-2014,
NPM-0154-2014
Diclofenac sodium 100 mg/tabBP-2013,
CP-2010,
MNP-2011,
NPM-023-2015,
NPM-0270-2016,
NPM-0115-2014
Ibuprofen, 400 mg /tabBP-2013,
BP-2015,
Registration document
Metronidazole 0.5%/100 ml infusion solutionCP-2010,
Registration document,
USP-36,
Nystatin 500,000 IU/tabBP-2013,
USP-36,
Registration document
Omeprazole 20 mg/capsuleBP-2013,
Registration document
Panangin (Aspartic Acid, L- potassium and magnesium), 298 mg/tabRegistration document
Sildenafil citrate 100 mg/tabNPM-0254-2016,
Registration document
  1. Note: BP British Pharmacopeia, CP Chinese Pharmacopeia, MNP Mongolian National Pharmacopeia, NPM National Pharmacopeial Monograph, USP United States Pharmacopeias